Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginInterest Coverage RatioInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

Pliant Therapeutics (PLRX) Net Margin (2020 - 2025)

Historic Net Margin for Pliant Therapeutics (PLRX) over the last 5 years, with Q3 2025 value amounting to 3227.12%.

  • Pliant Therapeutics' Net Margin changed N/A to 3227.12% in Q3 2025 from the same period last year, while for Sep 2025 it was 7243.05%, marking a year-over-year change of. This contributed to the annual value of 10211.14% for FY2023, which is 89378200.0% down from last year.
  • As of Q3 2025, Pliant Therapeutics' Net Margin stood at 3227.12%.
  • In the past 5 years, Pliant Therapeutics' Net Margin registered a high of 7029.54% during Q1 2025, and its lowest value of 16609.68% during Q2 2023.
  • Its 4-year average for Net Margin is 1211.25%, with a median of 1276.19% in 2021.
  • Per our database at Business Quant, Pliant Therapeutics' Net Margin soared by 6839600bps in 2022 and then crashed by -160174500bps in 2023.
  • Over the past 4 years, Pliant Therapeutics' Net Margin (Quarter) stood at 1227.16% in 2021, then plummeted by -45bps to 1784.22% in 2022, then plummeted by -831bps to 16609.68% in 2023, then soared by 119bps to 3227.12% in 2025.
  • Its last three reported values are 3227.12% in Q3 2025, 5352.29% for Q2 2025, and 7029.54% during Q1 2025.